Here are 15 key notes on orthopedic and spine device companies from the past week.
Zimmer Biomet resolved an issue involving allegations Biomet violated U.S. Foreign Corrupt Policies Act before the companies merged, paying a $30.5 million settlement.
Johnson & Johnson Medical Device Companies launched their Orthopaedic Episode of Care Approach, an offering to help health systems and surgeons reduce costs and increase quality for value-based alternative care models in orthopedics.
Kalamazoo, Mich.-based Stryker is expected to report net sales of $11.3 billion for 2016, according to the company's preliminary fourth quarter and full year financial report.
Leesburg, Va.-based K2M's full-year 2016 revenue will likely reach between $236.1 million and $236.6 million, according to preliminary financial results for the fourth quarter and full year of 2016, ended Dec. 31.
Carlsbad, Calif.-based SeaSpine reported preliminary and unaudited revenue will hit between $32.5 million and $32.7 million for Q4 2016.
Lewisville, Texas-based Orthofix International received FDA approval for its CervicalStim and SpinalStim bone growth stimulators.
Atlanta-based Medovex Corp. entered into an international distribution agreement with AlfaMed, an Italy-based spine surgery equipment supplier.
Marietta, Ga.-based Amendia named Gary Maingot the new executive vice president of operations.
Walnut Creek, Calif.-based Providence Medical Technology appointed Gregory S. Curhan the new CFO and senior vice president of corporate development.
Israel-based Expanding Orthopedics reported a more than 100 percent revenue growth for its FLXfit expandable cage in the second half of 2016.
Lyon, France-based Medicrea filed its 510(k) submission to the FDA for its 3-D-printed titanium spinal interbody devices.
Whale Imaging, based in Waltham, Mass., unveiled its G-Arm B6 Duo.
Spinal Simplicity, based in Overland Park, Kan., received six new patents in 2016.
The U.S. Patent Office allowed Carlsbad, Calif.-based Aurora Spine's patent application, titled "Polyaxial Interspinous Fusion Implant and Bone Growth Stimulation System."
Cambridge, Mass.-based InVivo Therapeutics added Providence-based Rhode Island Hospital to its INSPIRE study.